Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,870 public trials 2,109 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Completed

Real-world Experience of ICIs Plus Chemotherapy for Advanced ESCC.

NCT05142709

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations
  • The 2nd affiliated hospital of Bengbu medical University Bengbu, Anhui, China
  • The 2nd people's hospital of Anhui province Hefei, Anhui, China
  • Fujian Cancer Hospital & Fujian Medical University Cancer Hospital Fuzhou, Fujian, China
  • The 1st affiliated hospital of Xiamen University Xiamen, Fujian, China
View all 23 locations
View Trial Details
Completed

Safety and Efficacy of Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) Versus Lenvatinib as First-line Therapy in Participants With Advanced Hepatocellular Carcinoma (MK-7902-002/E7080-G000-311/LEAP-002)

NCT03713593

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • The University of Arizona Cancer Center - North Campus ( Site 0621) Tucson, Arizona, United States
  • City of Hope Comprehensive Cancer Center ( Site 0587) Duarte, California, United States
  • Scripps Health ( Site 0644) La Jolla, California, United States
  • Pacific Hematology Oncology Associates ( Site 0588) San Francisco, California, United States
View all 172 locations
View Trial Details
Completed

Study of First-line Pembrolizumab (MK-3475) With Lenvatinib (MK-7902/E7080) in Urothelial Carcinoma Cisplatin-ineligible Participants Whose Tumors Express Programmed Cell Death-Ligand 1 and in Participants Ineligible for Platinum-containing Chemotherapy (MK-7902-011/E7080-G000-317/ LEAP-011)

NCT03898180

Conditions
Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +4 more
Locations
  • Banner MD Anderson Cancer Center ( Site 0016) Gilbert, Arizona, United States
  • Community Cancer Institute ( Site 0777) Clovis, California, United States
  • University of California Irvine Medical Center ( Site 0078) Orange, California, United States
  • John Wayne Cancer Institute ( Site 0017) Santa Monica, California, United States
View all 194 locations
View Trial Details
Completed

Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence

NCT04054557

Conditions
Breast Carcinoma In Situ, Breast Diseases, Breast Neoplasms, +19 more
Locations
  • Jefferson Health - South Jersey Washington Township, New Jersey, United States
  • Thomas Jefefrson University Philadelphia, Pennsylvania, United States
  • Methodist Hospital Philadelphia, Pennsylvania, United States
  • Jefferson Health - Northeast Torresdale, Pennsylvania, United States
View Trial Details
Completed

Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)

NCT03040999

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • UCLA Medical Center ( Site 0273) Los Angeles, California, United States
  • University of California San Francisco ( Site 0274) San Francisco, California, United States
  • St. Joseph Heritage Healthcare ( Site 0254) Santa Rosa, California, United States
  • Smilow Cancer Hospital at Yale New Haven ( Site 0256) New Haven, Connecticut, United States
View all 151 locations
View Trial Details

Related conditions